올레마 파마슈티컬스, Inc.
US ˙ NasdaqGS ˙ US68062P1066

SecurityOLMA / Olema Pharmaceuticals, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership103,173 shares
Latest Disclosed Value $ 439,516
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series reports 50.18% increase in ownership of OLMA / Olema Pharmaceuticals, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 103,173 shares of Olema Pharmaceuticals, Inc. (US:OLMA) valued at $439,517 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 68,701 shares of Olema Pharmaceuticals, Inc.. This represents a change in shares of 50.18% during the quarter. The current value of the position is $1,063,714 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Olema Pharmaceuticals EC US68062P1066 103,173 34,472 50.18 440 70.16 0.0099
2025-05-28 2025-03-31 NP Olema Pharmaceuticals EC US68062P1066 68,701 0 0.00 258 -35.50 0.0062
2025-02-25 2024-12-31 NP Olema Pharmaceuticals EC US68062P1066 68,701 -10,906 -13.70 401 -57.89 0.0087
2024-11-26 2024-09-30 NP Olema Pharmaceuticals EC US68062P1066 79,607 30,886 63.39 951 80.27 0.0180
2024-08-26 2024-06-30 NP Olema Pharmaceuticals EC US68062P1066 48,721 0 0.00 527 -4.36 0.0107
2024-05-28 2024-03-31 NP Olema Pharmaceuticals EC US68062P1066 48,721 0 0.00 552 -19.33 0.0115
2024-02-26 2023-12-31 NP Olema Pharmaceuticals EC US68062P1066 48,721 3,091 6.77 684 21.31 0.0146
2023-11-28 2023-09-30 NP Olema Pharmaceuticals EC US68062P1066 45,630 0 0.00 564 36.65 0.0147
2023-08-25 2023-06-30 NP Olema Pharmaceuticals EC US68062P1066 45,630 45,630 412 0.0098
2022-08-25 2022-06-30 NP Olema Pharmaceuticals EC US68062P1066 0 -38,665 -100.00 0 -100.00
2022-05-26 2022-03-31 NP Olema Pharmaceuticals EC US68062P1066 38,665 0 0.00 165 -54.57 0.0038
2022-02-25 2021-12-31 NP Olema Pharmaceuticals EC US68062P1066 38,665 0 0.00 362 -66.10 0.0078
2021-11-24 2021-09-30 NP Olema Pharmaceuticals EC US68062P1066 38,665 21,159 120.87 1,066 117.79 0.0235
2021-08-26 2021-06-30 NP Olema Pharmaceuticals EC US68062P1066 17,506 5,979 51.87 490 28.01 0.0105
2021-05-27 2021-03-31 NP Olema Pharmaceuticals EC US68062P1066 11,527 11,527 382 0.0087
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.